查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球即时检测的成长机会
市场调查报告书
商品编码
1395900

全球即时检测的成长机会

Global Point-of-care Testing Growth Opportunities
出版日期: | 出版商: Frost & Sullivan | 英文 79 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

分子 POCT 释放分散式诊断资料生态系统的成长潜力

本研究概述了全球即时检测 (POCT) 产业。 POCT 是指在患者进行治疗或手术的地点或附近快速进行的常规或专门的实验室病理学测试。 COVID-19 的加剧正在改变全球诊断格局。医疗保健环境的整合趋势、结构性转变，以及 POCT 扩展到性行为感染(STI)、抗菌素抗药性 (AMR)、常规检测、肿瘤学和新生儿筛检，正在创造新的领域。未来，肿瘤、中风和失智症等治疗领域可能会成为 POCT 的一部分。

在新兴经济体，症状检测的广泛普及、免疫检测中多重检测的渗透、核酸扩增技术的进步（从 PCR 到等温扩增）、唾液检体的使用以及抗菌素抗药性检测的进步推动了市场活力的不断增强。此外，支援人工智慧/机器学习的设备软体功能以及诊断资料计划倡议下指定的变更管理计划正在加速美国的市场机会。

在新兴经济体，多参数平台不断涌现，以满足部门和中小型实验室对 POC 不断增长的需求。此外，人们对预防医学的浓厚兴趣正在为使用新的血液检测平台进行常规检测奠定基础。

强大的多重生态系统加上诊断资料融合创造新收益流（例如连接和数位医疗技术服务）的潜力，将支持摆脱 COVID-19 测试和改变临床途径。对类似测试的适应体现了更大的协调性基于实验室和非实验室的诊断资料，以创建更永续的护理点生态系统。

目录

战略问题

  • 为什么成长如此困难？
  • The Strategic Imperative 8（TM）
  • 床边检测 (POCT) 产业三大策略重点的影响
  • 成长机会加速Growth Pipeline Engine（TM）

成长机会分析

  • 分析范围
  • 细分-检查类型
  • 细分 - 护理连续体
  • 主要竞争
  • 成长指标
  • 生长促进因子
  • 成长抑制因素
  • 预测假设
  • 收益预测
  • 按测试类型分類的收益预测
  • 地区收益预测
  • 按护理连续体分類的收益预测
  • 预测分析
  • 价格趋势和预测分析
  • 竞争环境
  • POCT在各个治疗领域的应用
  • 收益占有率
  • 收益占有率分析
  • 竞争矩阵 - 治疗领域
  • 竞争矩阵 - 技术映射

生长机会分析 - 免疫化学 POCT

  • 成长指标
  • 收益预测
  • 地区收益预测
  • 免疫化学POCT收益预测
  • 预测分析

成长机会分析 - 分子 POCT

  • 成长指标
  • 收益预测
  • 地区收益预测
  • 分子POCT治疗领域收益预测
  • 预测分析

成长机会宇宙

  • 成长机会1：分子POCT
  • 成长机会 2：多重化
  • 成长机会3：STI POCT
  • 成长机会4：AMR POCT
  • 成长机会 5：常规 POCT
  • 成长机会6：智慧型手机POCT
  • POCT 在护理连续体中的未来

下一步

  • 下一步
  • 为什么是霜冻，为什么是现在？
  • 附件清单
  • 免责声明
简介目录
Product Code: K973-55

Molecular POCT Unlocking Growth Potential in the Distributed Diagnostic Data Ecosystem

This study provides an overview of the global point-of-care testing (POCT) industry, which refers to any routine or specialized lab pathology testing conducted rapidly, on-site/near the site of the patient, where care or treatment is provided. COVID-19 radicalization is changing the global diagnostics landscape. Consolidation trends, structural shifts in healthcare settings, and the extension of POCT to sexually transmitted infections (STIs), antimicrobial resistance (AMR), routine testing, oncology, and newborn screening are shaping new frontiers. In the future, therapy areas such as oncology, stroke, and dementia will represent the POCT repertoire.

In developed economies, the proliferation of syndromic testing, multiplexing making inroads in immunoassay, evolution in nucleic acid amplification technology (from PCR to Isothermal Amplification), the use of saliva specimens, and advancements in antimicrobial resistance testing are increasing the market viability. Furthermore, AI/ML-enabled device software functions incorporating predetermined change control plans under the diagnostic data program initiative offer accelerated market opportunities in the United States.

In developing economies, multiparametric platforms have emerged to respond to an escalating POC demand in emergency departments and small-medium labs. In addition, a strong pull toward preventive health is laying the foundation to advance routine testing using emerging blood testing platforms.

A robust multiplex ecosystem tied with the converging potential of diagnostic data creating new revenue streams (e.g., connectivity and digital healthcare technology services) exemplifies the pivot from COVID-19 testing, adapting to changing clinical pathways and greater harmonization of lab-based and non-lab-based diagnostic data for similar tests to build a more sustainable point-of-care ecosystem.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Point-of-care Testing (POCT) Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation-Test Type
  • Segmentation-Care Continuum
  • Key Competitors
  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Test Type
  • Revenue Forecast by Region
  • Revenue Forecast by Care Continuum
  • Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Competitive Environment
  • POCT Across Different Therapy Areas
  • Revenue Share
  • Revenue Share Analysis
  • Competitor Matrix-Therapy Areas
  • Competitor Matrix-Technology Mapping

Growth Opportunity Analysis- Immunochemistry POCT

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Revenue Forecast by Immunochemistry POCT
  • Forecast Analysis

Growth Opportunity Analysis-Molecular POCT

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Revenue Forecast by Molecular POCT Therapy Areas
  • Forecast Analysis

Growth Opportunity Universe

  • Growth Opportunity 1: Molecular POCT
  • Growth Opportunity 2: Multiplexing
  • Growth Opportunity 3: STI POCT
  • Growth Opportunity 4: AMR POCT
  • Growth Opportunity 5: Routine POCT
  • Growth Opportunity 6: Smartphone POCT
  • Future of POCT in Care Continuum

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer